Alpha Emitter Market By Type of Radionuclide (Lead-212, Actinium-225, Astatine-211, Radium-223, Bismuth-213, and Others), By Source (Natural Sources (Radium-226 and Uranium-238) and Artificially Produced Sources (Americium, Curium, Plutonium, and Californium)), By Application (Prostate Cancer, Bone Metastases, Pancreatic Cancer, Ovarian Cancer, Neuroendocrine Tumors, and Others), By End-user (Hospitals, Diagnostic Centers, Specialty Clinics, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: July 2024
- Report ID: 124979
- Number of Pages: 374
- Format:
-
-
-
- Telix Pharmaceuticals Ltd.
- RadioMedix Inc.
- IBA Radiopharma Solutions
- Fusion Pharmaceuticals
- Bayer AG Company Profile
- Alpha Tau Medical Ltd
- Actinium Pharmaceutical Inc.
- Orano Med
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible